The increasing demand for specific immunological investigation and therapeutic design has spurred significant progress in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently manufactured using diverse expression methods, including microbial hosts, mammalian cell populations, a